Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant

Abstract

Adgrg6 (Gpr126) is an adhesion class G protein-coupled receptor with a conserved role in myelination of the peripheral nervous system. In the zebrafish, mutation of adgrg6 also results in defects in the inner ear: otic tissue fails to down-regulate versican-gene expression and morphogenesis is disrupted. We have designed a whole-animal screen that tests for rescue of both up- and down-regulated gene expression in mutant embryos, together with analysis of weak and strong alleles. From a screen of 3120 structurally diverse compounds, we have identified 68 that reduce versican-b expression in the adgrg6 mutant ear, 41 of which also restore myelin basic protein gene expression in Schwann cells of mutant embryos. Nineteen compounds unable to rescue a strong adgrg6 allele provide candidates for molecules that may interact directly with the Adgrg6 receptor. Our pipeline provides a powerful approach for identifying compounds that modulate GPCR activity, with potential impact for future drug design.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Table 1 and Figure1-figure supplement 1, Figure 3, Figure 7 and Figure 7-figure supplements. Links to interactive files are given in the manuscript and in a supplemental file.

Article and author information

Author details

  1. Elvira Diamantopoulou

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9336-7965
  2. Sarah Baxendale

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6760-9457
  3. Antonio de la Vega de León

    Information School, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  4. Anzar Asad

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  5. Celia J Holdsworth

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  6. Leila Abbas

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  7. Valerie J Gillet

    Information School, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  8. Giselle R Wiggin

    Sosei Heptares, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  9. Tanya T Whitfield

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    For correspondence
    t.whitfield@sheffield.ac.uk
    Competing interests
    Tanya T Whitfield, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1575-1504

Funding

Biotechnology and Biological Sciences Research Council (Project grant BB/J003050/1)

  • Sarah Baxendale
  • Tanya T Whitfield

University of Sheffield (PhD studentship 314420)

  • Tanya T Whitfield

Medical Research Council (G0802527)

  • Sarah Baxendale
  • Celia J Holdsworth
  • Leila Abbas
  • Tanya T Whitfield

European Union's Seventh Framework Programme (Grant agreement no. 612347)

  • Valerie J Gillet

Biotechnology and Biological Sciences Research Council (BB/R50581X/1)

  • Sarah Baxendale
  • Anzar Asad
  • Giselle R Wiggin
  • Tanya T Whitfield

Wellcome (VIP award 084551)

  • Leila Abbas
  • Tanya T Whitfield

Medical Research Council (G0700091)

  • Sarah Baxendale
  • Celia J Holdsworth
  • Leila Abbas
  • Tanya T Whitfield

Biotechnology and Biological Sciences Research Council (Project grant BB/M01021X/1)

  • Sarah Baxendale
  • Tanya T Whitfield

Biotechnology and Biological Sciences Research Council (ALERT14 equipment award BB/M012522/1)

  • Sarah Baxendale
  • Tanya T Whitfield

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. David A Lyons, University of Edinburgh, United Kingdom

Ethics

Animal experimentation: All animal work was performed under licence from the UK Home Office (P66302E4E), and approved by the University of Sheffield Ethical Review Committee (ASPA Ethical Review Process).

Version history

  1. Received: January 4, 2019
  2. Accepted: June 8, 2019
  3. Accepted Manuscript published: June 10, 2019 (version 1)
  4. Version of Record published: June 28, 2019 (version 2)

Copyright

© 2019, Diamantopoulou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,669
    Page views
  • 327
    Downloads
  • 17
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elvira Diamantopoulou
  2. Sarah Baxendale
  3. Antonio de la Vega de León
  4. Anzar Asad
  5. Celia J Holdsworth
  6. Leila Abbas
  7. Valerie J Gillet
  8. Giselle R Wiggin
  9. Tanya T Whitfield
(2019)
Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant
eLife 8:e44889.
https://doi.org/10.7554/eLife.44889

Share this article

https://doi.org/10.7554/eLife.44889

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Developmental Biology
    2. Neuroscience
    Smrithi Prem, Bharati Dev ... Emanuel DiCicco-Bloom
    Research Article

    Autism spectrum disorder (ASD) is defined by common behavioral characteristics, raising the possibility of shared pathogenic mechanisms. Yet, vast clinical and etiological heterogeneity suggests personalized phenotypes. Surprisingly, our iPSC studies find that six individuals from two distinct ASD-subtypes, idiopathic and 16p11.2 deletion, have common reductions in neural precursor cell (NPC) neurite outgrowth and migration even though whole genome sequencing demonstrates no genetic overlap between the datasets. To identify signaling differences that may contribute to these developmental defects, an unbiased phospho-(p)-proteome screen was performed. Surprisingly despite the genetic heterogeneity, hundreds of shared p-peptides were identified between autism subtypes including the mTOR pathway. mTOR signaling alterations were confirmed in all NPCs across both ASD-subtypes, and mTOR modulation rescued ASD phenotypes and reproduced autism NPC associated phenotypes in control NPCs. Thus, our studies demonstrate that genetically distinct ASD subtypes have common defects in neurite outgrowth and migration which are driven by the shared pathogenic mechanism of mTOR signaling dysregulation.